Go back to trials list
Erector Spinae Blocks for Thoracic Surgery
Description
The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.The research hypothesis for the ESB Thoracic study is that erector spinae blocks with boluses of bupivacaine infusions will decrease patients' postsurgical pain, and thereby decrease the amount of narcotic pain medication used. This will be of particular use in patients who have an anticoagulation need and are not able to receive more invasive nerve blocks.To achieve appropriate exposure for pulmonary resection surgery, whether open or video-assisted, patients have surgical incision in the lateral thoracic region, including disruption to the tributaries of the spinal nerves. Due to this dissection, patients frequently experience significant pain post-operatively. Erector spinae blocks with bupivacaine or ropivacaine with bolus infusion therapy have been shown to treat this spina
Trial Eligibility
Inclusion Criteria: * pulmonary resection * 18\<age\<90 Exclusion Criteria: * pleurodesis * decortication * emergent surgery * local anesthetic allergy * intraoperative complication (inadvertent hemorrhage or conversion to open surgery) * bilateral pulmonary resection
Study Info
Organization
George Washington University
Primary Outcome
Outcome Measure - Pain Score and Pain Medications (6 hours)
Interventions
Locations Recruiting
The George Washington University
United States, District of Columbia, Washington
Interested in joining this trial?
Our dedicated patient navigators are here to guide you through the validation and enrollment process with ease.
Get the latest thought leadership on your Blood Cancer delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.